Back to Search
Start Over
Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
- Source :
-
Infectious disease clinics of North America [Infect Dis Clin North Am] 2018 Jun; Vol. 32 (2), pp. 323-345. - Publication Year :
- 2018
-
Abstract
- An estimated 30% of Americans with hepatitis C virus (HCV) pass through a jail or prison annually. One in 7 incarcerated persons is viremic. Screening and treatment is cost-effective and beneficial to society as a whole. Yet at current (2018) levels of funding for HCV management, prisons are not aggressively seeking cases; few incarcerated persons with HCV actually receive treatment. This article explores barriers to screening for and treating hepatitis C in state prisons, and ways that states may overcome these barriers, such as nominal pricing. While high prices for direct-acting antivirals discourage treatment, potential strategies exist to lower prices.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Subjects :
- Antiviral Agents economics
Criminal Law
Disease Eradication methods
Disease Eradication statistics & numerical data
Female
Hepacivirus drug effects
Hepatitis C epidemiology
Hepatitis C prevention & control
Hepatitis C transmission
Humans
Male
Mass Screening
Medicaid
Prevalence
Prisoners statistics & numerical data
Prisons economics
Substance Abuse, Intravenous complications
Substance Abuse, Intravenous virology
United States epidemiology
Antiviral Agents therapeutic use
Disease Eradication legislation & jurisprudence
Disease Management
Hepatitis C drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1557-9824
- Volume :
- 32
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Infectious disease clinics of North America
- Publication Type :
- Academic Journal
- Accession number :
- 29778259
- Full Text :
- https://doi.org/10.1016/j.idc.2018.02.014